TrialSignal transduction and targeted therapy2024

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial.

Xuhua Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.